Edwards Lifesciences (EW) EBT Margin (2009 - 2026)

Edwards Lifesciences' EBT Margin history runs 18 years deep, the most recent figure standing at 27.84% for Q1 2026.

• In Q1 2026, EBT Margin fell 287.0% year-over-year to 27.84%; the TTM figure through Mar 2026 stood at 20.59% (down 858.0% YoY), while the FY2025 annual figure was 20.98%, down 748.0% from the prior year.
• EBT Margin was 27.84% for Q1 2026 at Edwards Lifesciences, up from 5.76% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 49.17% in Q4 2022 to a low of 5.76% in Q4 2025.
• Historically, EBT Margin has averaged 28.67% across 5 years, with a median of 29.0% in 2023.
• The sharpest annual moves came in 2022 and 2025: EBT Margin jumped 2087 bps in 2022, then tumbled 2239 bps in 2025.
• A 5-year view of EBT Margin shows it stood at 49.17% in 2022, then tumbled by 41 bps to 29.0% in 2023, then dropped by 3 bps to 28.15% in 2024, then plunged by 80 bps to 5.76% in 2025, then soared by 383 bps to 27.84% in 2026.
• The last three EBT Margin figures came in at 27.84% (Q1 2026), 5.76% (Q4 2025), and 22.43% (Q3 2025), per Business Quant data.